Literature DB >> 2469502

Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythroid, myeloid, and multipotential progenitor cells.

D Rennick1, J Jackson, G Yang, J Wideman, F Lee, S Hudak.   

Abstract

The growth-promoting activities of interleukin-6 (IL-6) in combination with different factors were assessed in bone marrow (BM) cultures prepared from normal mice and from mice treated with 5-fluorouracil (5-FU). Effects on hematopoietic colony formation with respect to number, size, and cellular composition were evaluated. In agreement with previous reports, IL-6 acts synergistically with IL-3 to stimulate increased numbers of granulocyte/macrophage (GM) and multilineage colonies in day-2 and day-4 post-5-FU BM cultures. Furthermore, day 4 but not day 2 post-5-FU BM showed enhanced GM colony formation when stimulated with IL-6 plus interleukin-4 (IL-4) or granulocyte colony-stimulating factor (G-CSF). In contrast, IL-6 did not increase the number of colonies supported by M-CSF or GM-CSF. Nevertheless IL-6 interacted with all factors, including M-CSF and GM-CSF, to stimulate an increase in colony size. Many of these myeloid colonies attained a diameter of greater than or equal to 0.5 mm, suggesting they derive from high proliferative potential cells (HPP-CFC). The response of normal and day-8 post-5-FU BM containing high numbers of more mature progenitors was also assessed. We found IL-6 enhanced colony formation by lineage-restricted megakaryocytic and erythroid progenitors in the presence of IL-3 and IL-4 plus erythropoietin (Epo), respectively. The sum of these results shows that IL-6 interacts with a variety of factors to regulate the growth of progenitor cells at different stages of lineage commitment and maturation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2469502

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Acetylation impacts Fli-1-driven regulation of granulocyte colony stimulating factor.

Authors:  Mara L Lennard Richard; Danielle Brandon; Ning Lou; Shuzo Sato; Tomika Caldwell; Tamara K Nowling; Gary Gilkeson; Xian K Zhang
Journal:  Eur J Immunol       Date:  2016-08-16       Impact factor: 5.532

2.  Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells.

Authors:  D M Bodine; S Karlsson; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 3.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

4.  Human recombinant erythropoietin directly stimulates B cell immunoglobulin production and proliferation in serum-free medium.

Authors:  H Kimata; A Yoshida; C Ishioka; S Masuda; R Sasaki; H Mikawa
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

5.  Cytokine production by a megakaryocytic cell line.

Authors:  B Sandrock; K M Hudson; D E Williams; M A Lieberman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

6.  Stimulation of thrombopoiesis in mice by human recombinant interleukin 6.

Authors:  R J Hill; M K Warren; J Levin
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 7.  The Jeremiah Metzger lecture. Regulation of hematopoiesis.

Authors:  D G Nathan
Journal:  Trans Am Clin Climatol Assoc       Date:  1990

8.  The genes for leukemia inhibitory factor and interleukin-6 are expressed in mouse blastocysts prior to the onset of hemopoiesis.

Authors:  R Murray; F Lee; C P Chiu
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

9.  Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells.

Authors:  K Akashi; T Shibuya; M Harada; Y Takamatsu; N Uike; T Eto; Y Niho
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

10.  Dedifferentiated chondrosarcoma with leukocytosis and elevation of serum G-CSF. A case report.

Authors:  Akio Sakamoto; Hidetaka Yamamoto; Kazuhiro Tanaka; Shuichi Matsuda; Katsumi Harimaya; Yoshinao Oda; Masazumi Tsuneyoshi; Yukihide Iwamoto
Journal:  World J Surg Oncol       Date:  2006-07-04       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.